Solid Support Systems

A growing ophthalmic portfolio offering quality-focused solutions across diverse therapeutic requirements.

A diverse range of oral solutions designed for flexible and patient-friendly administration.

Quality-focused oral suspension formulations supporting diverse therapeutic applications and patient needs.

Pellet-based dosage forms offering flexible solutions for diverse pharmaceutical applications.

Convenient and patient-focused delivery formats designed for modern pharmaceutical needs.

Polymer chemistry capabilities supporting diverse pharmaceutical applications through strong expertise, quality and scalable solutions.

Patient-focused sublingual dosage forms supporting convenient and effective drug delivery.

A broad range of syrup formulations developed to support diverse patient and therapeutic needs.

A comprehensive tablet portfolio spanning diverse therapeutic categories and patient needs.

A versatile portfolio of vial-based products supported by reliable manufacturing and quality standards.

API

Growing capabilities in complex peptides, combining advanced expertise, quality-focused processes and reliable support for pharmaceutical partners

MSN Group is one of the fastest-growing, research-based and fully integrated pharmaceutical companies based out of Hyderabad, India. It was founded in the year 2003 with a mission to make high-quality medicines affordable and accessible to the world. The organization presently has 24 state-of-the-art manufacturing facilities (16 API and 8 Finished Dosage Facilities) established across India and USA. The group has an integrated R&D centre that facilitates the research of both API and Finished Dosages under one roof, enabling the organization to introduce new and affordable therapies in global markets swiftly.